scholarly journals The Cervix Cancer Research Network: A Global Outreach Effort on Behalf of the Gynecologic Cancer InterGroup

2015 ◽  
Vol 92 (3) ◽  
pp. 506-508 ◽  
Author(s):  
David K. Gaffney ◽  
Gita Suneja ◽  
Sang Young Ryu ◽  
Mary McCormick ◽  
Marie Plante ◽  
...  
Keyword(s):  
Cancer Research ◽  
Gynecologic Cancer ◽  
Cervix Cancer ◽  
Research Network ◽  
Cancer Research Network ◽  
Outreach Effort

Cervical cancer in Eastern Europe: review and proceedings from the Cervical Cancer Research Conference

2020 ◽  
pp. ijgc-2020-001652
Author(s):  
William Small Jr ◽  
Gheorghe Peltecu ◽  
Anastasia Puiu ◽  
Andrei Corha ◽  
Elena Cocîrṭă ◽  
...  
Keyword(s):  
Cervical Cancer ◽  
Cancer Research ◽  
Clinical Trials ◽  
Gynecologic Cancer ◽  
Cervix Cancer ◽  
Research Network ◽  
Cancer Research Network ◽  
Common Cancer ◽  
Educational Symposium ◽  
The Subject

Cervical cancer is the third most common cancer among women worldwide, with a disproportionately high burden of disease in less-developed regions of the world. The Cervix Cancer Research Network was founded by the Gynecologic Cancer InterGroup with a mission to improve outcomes in cervical cancer by enhancing international access to clinical trials, specifically in under-represented, underdeveloped areas. The Cervix Cancer Research Network held its third international educational symposium in Bucharest in 2018 and is the subject of this report. The purpose of this symposium was to advance the international understanding of cervical cancer treatment patterns, to foster recruitment to Cervix Cancer Research Network clinical trials, and identify key Cervix Cancer Research Network clinical trial concepts to improve cervical cancer care worldwide.

Cervix Cancer Research Network (CCRN): Improving Access to Cervix Cancer Trials on a Global Scale

2016 ◽  
Vol 26 (9) ◽  
pp. 1690-1693 ◽  
Author(s):  
David Gaffney ◽  
Bill Small ◽  
Henry Kitchener ◽  
Sang Young Ryu ◽  
Akila Viswanathan ◽  
...  
Keyword(s):  
Cancer Research ◽  
Clinical Trials ◽  
Gynecologic Cancer ◽  
The United States ◽  
Global Scale ◽  
Cervix Cancer ◽  
Research Network ◽  
Standards Of Care ◽  
Cancer Research Network ◽  
The World

AbstractEighty-seven percent of cervix cancer occurs in less-developed regions of the world, and there is up to an 18-fold difference in mortality rate for cervix cancer depending on the region of the world. The Cervix Cancer Research Network (CCRN) was founded through the Gynecologic Cancer InterGroup with the aim of improving access to clinical trials in cervix cancer worldwide, and in so doing improving standards of care. The CCRN recently held its first international educational symposium in Bangkok. Sixty-two participants attended from 16 different countries including Pakistan, India, Bangladesh, Thailand, Malaysia, Singapore, Philippines, Taiwan, China, Vietnam, Korea, Japan, Columbia, Brazil, Canada, and the United States. The focus of this symposium was to evaluate progress, to promote new clinical trials for the CCRN, and to provide education regarding the role of brachytherapy in the treatment of cervical cancer.

scholarly journals The Cervical Cancer Research Network (Gynecologic Cancer InterGroup) roadmap to expand research in low- and middle-income countries

2021 ◽  
Vol 31 (5) ◽  
pp. 775-778
Author(s):  
Mary McCormack ◽  
David Gaffney ◽  
David Tan ◽  
Kathy Bennet ◽  
Adriana Chavez-Blanco ◽  
...  
Keyword(s):  
Cervical Cancer ◽  
Cancer Research ◽  
New Technologies ◽  
Gynecologic Cancer ◽  
Research Network ◽  
World Health ◽  
Middle Income ◽  
Cancer Research Network ◽  
Middle Income Countries ◽  
Low And Middle Income

Cervical cancer is a global health problem which disproportionally affects women in low- and middle- income countries. The World Health Organization recently launched its global strategy to eliminate this disease in the next two decades. For those women diagnosed today with cervical cancer better strategies are needed to improve outcome and reduce treatment-related morbidity. Clinical trials are critical to shaping future treatment, and much has been achieved already. However, such opportunities are limited in low resource settings, and the Cervical Cancer Research Network is dedicated to expanding access to new technologies in surgery, radiation, and medical oncology. In this article we review the status of the trials portfolio and outline future objectives, including the launch of a number of research grants for aspiring or established researchers in low- and middle-income settings

scholarly journals PS1-23: Capitalizing on the HMO Cancer Research Network (CRN): The Optimal Setting to Conduct Studies of Rare Complex Diseases

2013 ◽  
Vol 11 (3) ◽  
pp. 128-128
Author(s):  
C. C. Johnson ◽  
C. Chao ◽  
L. Engel ◽  
H. Feigelson ◽  
J. Fortuny ◽  
...  
Keyword(s):  
Cancer Research ◽  
Complex Diseases ◽  
Research Network ◽  
Cancer Research Network ◽  
Optimal Setting

scholarly journals The kidney cancer research priority-setting partnership: Identifying the top 10 research priorities as defined by patients, caregivers, and expert clinicians

2017 ◽  
Vol 11 (12) ◽  
pp. 379-87 ◽  
Author(s):  
Jennifer Jones ◽  
Jaimin Bhatt ◽  
Jonathan Avery ◽  
Andreas Laupacis ◽  
Katherine Cowan ◽  
...  
Keyword(s):  
Cancer Research ◽  
Kidney Cancer ◽  
Priority Setting ◽  
Research Priorities ◽  
Research Network ◽  
Cancer Research Network ◽  
Research Priority ◽  
Funding Agencies ◽  
James Lind Alliance ◽  
Priority Setting Partnership

It is critically important to define disease-specific research priorities to better allocate limited resources. There is growing recognition of the value of involving patients and caregivers, as well as expert clinicians in this process. To our knowledge, this has not been done this way for kidney cancer. Using the transparent and inclusive process established by the James Lind Alliance, the Kidney Cancer Research Network of Canada (KCRNC) sponsored a collaborative consensus-based priority-setting partnership (PSP) to identify research priorities in the management of kidney cancer. The final result was identification of 10 research priorities for kidney cancer, which are discussed in the context of current initiatives and gaps in knowledge. This process provided a systematic and effective way to collaboratively establish research priorities with patients, caregivers, and clinicians, and provides a valuable resource for researchers and funding agencies.

166: Searching for MARS-2: The North Trent Cancer Research Network Specialist Mesothelioma MDT screening experience

Lung Cancer ◽  
2017 ◽  
Vol 103 ◽  
pp. S76-S77
Author(s):  
S. Ajab ◽  
S.S.S. Begum ◽  
H. Stanley ◽  
S. Matthews ◽  
P.M. Fisher ◽  
...  
Keyword(s):  
Cancer Research ◽  
Research Network ◽  
Cancer Research Network ◽  
The North
Sign in / Sign up

Export Citation Format

Share Document